Opioid-Induced Constipation (OIC) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Opioids are effective pain relievers, but often have the side effect of constipation. These medicines affect the gastrointestinal tract in a variety of ways. Opioids increase the amount of time it takes stool to move through the gastric system. They increase non-propulsive contractions in the middle of the small intestine (jejunum) and decrease longitudinal propulsive peristalsis – motions critical to moving food through the intestines. Additionally, opioids reduce digestive secretions and decrease the urge to defecate. Symptoms of Opioid-Induced Constipation (OIC) include feeling and being sick, tiredness and lethargy, appetite loss, and feeling depressed.
The Opioid-Induced Constipation (OIC) Drugs in Development market research report provides an overview of the OIC pipeline landscape. The report provides comprehensive information on the therapeutics under development for Opioid-Induced Constipation (OIC), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Opioid-Induced Constipation (OIC) and features dormant and discontinued projects.
OIC Pipeline Drugs Market Targets
The targets of the OIC pipeline drugs market are Mu Type Opioid Receptor, 5-Hydroxytryptamine Receptor 4, and Chloride Channel Protein 2.
OIC pipeline drugs market, by targets
For more target insights, download a free report sample
Mechanisms of Action of OIC Pipeline Drugs Market
The mechanisms of action of the OIC pipeline drugs market are Mu Type Opioid Receptor Antagonist, 5-Hydroxytryptamine Receptor 4 Agonist, and Chloride Channel Protein 2 Activator.
OIC pipeline drugs market, by mechanisms of action
For more mechanisms of action insights, download a free report sample
Routes of Administration in OIC Pipeline Drugs Market
The route of administration in the OIC pipeline drugs market is oral.
Molecule Types in OIC Pipeline Drugs Market
The molecule types in the OIC pipeline drugs market are small molecule and biologic.
OIC pipeline drugs market, by molecule types
For more molecule type insights, download a free report sample
Key OIC Pipeline Drugs Market Companies
Some of the key companies in the OIC pipeline drugs market are BioGaia Pharma AB, Mallinckrodt Plc, PegBio Co Ltd, Shanghai Hanmai Biomedical Technology Co Ltd, Shionogi & Co Ltd, and Yuhan Corp.
OIC pipeline drugs market, by key companies
To know more about key companies, download a free report sample
Market report overview
Targets | Mu Type Opioid Receptor, 5-Hydroxytryptamine Receptor 4, and Chloride Channel Protein 2 |
Mechanisms of Action | Mu Type Opioid Receptor Antagonist, 5-Hydroxytryptamine Receptor 4 Agonist, and Chloride Channel Protein 2 Activator |
Routes of Administration | Oral |
Molecule Types | Small Molecule and Biologic |
Key Companies | BioGaia Pharma AB, Mallinckrodt Plc, PegBio Co Ltd, Shanghai Hanmai Biomedical Technology Co Ltd, Shionogi & Co Ltd, and Yuhan Corp |
Scope
This report provides:
- A snapshot of the global therapeutic landscape of Opioid-Induced Constipation (OIC) (Toxicology).
- Reviews of pipeline therapeutics for Opioid-Induced Constipation (OIC) (Toxicology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Pipeline products based on several stages of development ranging from pre-registration to discovery and undisclosed stages.
- Descriptive drug profiles for the pipeline products which include product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities.
- Reviews of key companies involved in Opioid-Induced Constipation (OIC) (Toxicology) therapeutics and enlists all their major and minor projects.
- Evaluation of Opioid-Induced Constipation (OIC) (Toxicology) targeted therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA), and molecule type.
- All the dormant and discontinued pipeline projects.
- Reviews of the latest news and deals related to pipeline therapeutics for Opioid-Induced Constipation (OIC) (Toxicology).
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Opioid-Induced Constipation (OIC) (Toxicology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Opioid-Induced Constipation (OIC) (Toxicology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Mallinckrodt Plc
PegBio Co Ltd
Shanghai Hanmai Biomedical Technology Co Ltd
Shionogi & Co Ltd
Yuhan Corp
Table of Contents
Table
Figures
Frequently asked questions
-
What are the targets of the OIC pipeline drugs market?
The targets of the OIC pipeline drugs market are Mu Type Opioid Receptor, 5-Hydroxytryptamine Receptor 4, and Chloride Channel Protein 2.
-
What are the mechanisms of action of the OIC pipeline drugs market?
The mechanisms of action of the OIC pipeline drugs market are Mu Type Opioid Receptor Antagonist, 5-Hydroxytryptamine Receptor 4 Agonist, and Chloride Channel Protein 2 Activator.
-
What are the routes of administration in the OIC pipeline drugs market?
The route of administration in the OIC pipeline drugs market is oral.
-
What are the molecule types in the OIC pipeline drugs market?
The molecule types in the OIC pipeline drugs market are small molecule and biologic.
-
Which are the key companies in the OIC pipeline drugs market?
Some of the key companies in the OIC pipeline drugs market are BioGaia Pharma AB, Mallinckrodt Plc, PegBio Co Ltd, Shanghai Hanmai Biomedical Technology Co Ltd, Shionogi & Co Ltd, and Yuhan Corp.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.